This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Song, P. Articles by Spindel, E. R. Search for Related Content PubMed PubMed Citation Articles by Song, P. Articles by Spindel, E. R.

M3 Muscarinic Receptor Antagonists Inhibit Small Cell Lung Carcinoma Growth and Mitogen-Activated Protein Kinase Phosphorylation Induced by Acetylcholine Secretion

¹ Division of Neuroscience, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon; Departments of ² Pathology and ³ Behavioral Neuroscience, Oregon Health and Science University, Portland, Oregon; and ⁴ Department of Dermatology, University of California, Davis, California

Requests for reprints: Eliot Spindel, Division of Neuroscience, Oregon National Primate Research Center, Beaverton, OR 97006. Phone: 503-690-5512; Fax: 503-690-5384; E-mail: spindele{at}ohsu.edu.

The importance of acetylcholine as a neurotransmitter in the nervous system is well established, but little is yet known about its recently described role as an autocrine and paracrine hormone in a wide variety of nonneuronal cells. Consistent with the expression of acetylcholine in normal lung, small cell lung carcinoma (SCLC) synthesize and secrete acetylcholine, which acts as an autocrine growth factor through both nicotinic and muscarinic cholinergic mechanisms. The purpose of this study was to determine if interruption of autocrine muscarinic cholinergic signaling has potential to inhibit SCLC growth. Muscarinic receptor (mAChR) agonists caused concentration-dependent increases in intracellular calcium and mitogen-activated protein kinase (MAPK) and Akt phosphorylation in SCLC cell lines. The inhibitory potency of mAChR subtype–selective antagonists and small interfering RNAs (siRNAs) on acetylcholine-increased intracellular calcium and MAPK and Akt phosphorylation was consistent with mediation by M3 mAChR (M3R). Consistent with autocrine acetylcholine secretion stimulating MAPK and Akt phosphorylation, M3R antagonists and M3R siRNAs alone also caused a decrease in basal levels of MAPK and Akt phosphorylation in SCLC cell lines. Treatment of SCLC cells with M3R antagonists inhibited cell growth both in vitro and in vivo and also decreased MAPK phosphorylation in tumors in nude mice in vivo. Immunohistochemical staining of SCLC and additional cancer types showed frequent coexpression of acetylcholine and M3R. These findings suggest that M3R antagonists may be useful adjuvants for treatment of SCLC and, potentially, other cancers. [Cancer Res 2007;67(8):3936–44]

This article has been cited by other articles:

				N. Shah, S. Khurana, K. Cheng, and J.-P. Raufman Muscarinic receptors and ligands in cancer Am J Physiol Cell Physiol, February 1, 2009; 296(2): C221 - C232. [Abstract] [Full Text] [PDF]

				K. Cheng, R. Samimi, G. Xie, J. Shant, C. Drachenberg, M. Wade, R. J. Davis, G. Nomikos, and J.-P. Raufman Acetylcholine release by human colon cancer cells mediates autocrine stimulation of cell proliferation Am J Physiol Gastrointest Liver Physiol, September 1, 2008; 295(3): G591 - G597. [Abstract] [Full Text] [PDF]

				P. Song, H. S. Sekhon, X. W. Fu, M. Maier, Y. Jia, J. Duan, B. J. Proskosil, C. Gravett, J. Lindstrom, G. P. Mark, et al. Activated Cholinergic Signaling Provides a Target in Squamous Cell Lung Carcinoma Cancer Res., June 15, 2008; 68(12): 4693 - 4700. [Abstract] [Full Text] [PDF]